Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks
Market Update: Stocks Edge Up, Biotech Firm Enveda Reaches Unicorn Status

Market Update: Stocks Edge Up, Biotech Firm Enveda Reaches Unicorn Status

Newsdesk profile image
by Newsdesk

AI-Generated Summary

Stocks were fractionally higher Thursday morning, following a half-percentage point rise in the S&P 500 on Wednesday, fueled by Big Tech gains. Economic forecasts anticipate 75,000 private sector jobs added last month and a slight increase in August unemployment to 4.3%. Separately, clinical-stage biotech company Enveda announced it has achieved unicorn status, now valued over a billion dollars after its latest funding round.

In a nutshell

This update offers a concise look at current market dynamics, combining general stock performance with key economic indicators and a notable success story from the biotech sector. While market sentiment shows slight gains, the upcoming economic reports, particularly non-farm payrolls, will be crucial in shaping the broader financial outlook.


Source: The Manila Times

Newsdesk profile image
by Newsdesk

Be informed!

Rx.news delivers critical healthcare intelligence to pharmaceutical professionals, biotech innovators, healthcare investors, medical practitioners, and policy makers.

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Read More